发明授权
- 专利标题： Tetrahydro-beta-carbolines
- 专利标题（中）： 四氢-β-咔啉
-
申请号： US835774申请日： 1997-04-08
-
公开(公告)号： US5861409A公开(公告)日： 1999-01-19
- 发明人: James E. Audia , Stephen Richard Baker , Jesus Ezquerra Carrera , Carlos Lamas Peteira , Concepcion Pedregal Tercero
- 申请人： James E. Audia , Stephen Richard Baker , Jesus Ezquerra Carrera , Carlos Lamas Peteira , Concepcion Pedregal Tercero
- 申请人地址： IN Indianapolis
- 专利权人： Eli Lilly and Company
- 当前专利权人： Eli Lilly and Company
- 当前专利权人地址： IN Indianapolis
- 主分类号： C07D471/04
- IPC分类号： C07D471/04 ; A61K31/44
摘要：
The present invention provides novel tetrahydro-beta-carboline compounds having useful central nervous system activity. Further, there is provided tetrahydro-beta-carboline related compounds which are useful intermediates and have beneficial central nervous system activity. The invention provides formulations and methods for using the novel tetrahydro-beta-carboline and related compounds. Such compounds are particularly useful for the modulation of a 5-HT.sub.2B receptor.
公开/授权文献
- US4684106A Valve 公开/授权日：1987-08-04